Labetalol Hydrochloride Injection, Solution
Product Images NDC 68083-111

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 68083-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labetalol-spl-structure (Labetalol Spl Structure)

Chemical structure of Labetalol Hydrochloride, showing its aromatic rings, side chains with hydroxyl and amide groups, and the hydrochloride component.*

FDA Label Image

Labetalol-spl-label (Labetalol Spl Label)

Label for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) solution for intravenous injection. The multiple-dose vial contains 20 mL and is for prescription use only. Manufactured by Gland Pharma Limited, Hyderabad, India, the label includes storage instructions and preservatives information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.